Morphological Changes and Prognostic Factors before and after Photodynamic Therapy for Central Serous Chorioretinopathy
Central serous chorioretinopathy (CSC) is a disease of unknown etiology, but half-dose photodynamic therapy (hPDT) is well known to be effective for CSC. Infrared reflectance (IR) has been shown to be effective for detecting retinal pigmented epithelial and choroidal lesions, but no reports have foc...
Main Authors: | Yu Wakatsuki, Koji Tanaka, Ryusaburo Mori, Koichi Furuya, Akiyuki Kawamura, Hiroyuki Nakashizuka |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/1/53 |
Similar Items
-
Central Serous Chorioretinopathy: Pathogenesis and Management
by: Semeraro F, et al.
Published: (2019-12-01) -
Comprehensive evaluation of intravitreal conbercept versus half-dose photodynamic therapy for chronic central serous chorioretinopathy
by: Jian-Bo Mao, et al.
Published: (2021-05-01) -
Change in choroidal vascularity in acute central serous chorioretinopathy
by: Mohammed Abdul Rasheed, et al.
Published: (2018-01-01) -
No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy
by: Andrea Servillo, et al.
Published: (2023-06-01) -
Intravitreal Bevacizumab for Photodynamic Therapy-Induced Massive Macular Detachment in Acute Central Serous Chorioretinopathy
by: Maria G. Kotoula, et al.
Published: (2012-06-01)